PHARMACOSMOS A/S: Financial statements 2020
CVR: 15517085
Source: annual report 2020, Danish Business Authority
01/05/2019 – 30/04/2020
PHARMACOSMOS A/S (CVR 15517085) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 609,062,000 and a net result of DKK 56,457,000 compared with DKK 102,068,000 the year before. That is an increase of 6.3% compared with the year before. The profit margin was 9.3%. Equity in the 2020 report amounted to DKK 884,049,000. The solvency ratio was 65.8%. The company had 258 employees in the financial year.
- Revenue
- DKK 609,062,000
- Gross Profit
- DKK 328,856,000
- Profit/Loss
- DKK 56,457,000
- Equity
- DKK 884,049,000
- Total Assets
- DKK 1,344,417,000
- Employees
- 258
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 609.1 mio. | 328.9 mio. | 56.5 mio. | 884 mio. | 258 |
| 2019 | 573.1 mio. | 318 mio. | 102.1 mio. | 827 mio. | 236 |
| 2018 | 542.2 mio. | 314.5 mio. | 69.1 mio. | 720.8 mio. | 208 |
| 2017 | 511.6 mio. | 314.8 mio. | 158.7 mio. | 656.8 mio. | 172 |
| 2016 | 448 mio. | 254.5 mio. | 102.7 mio. | 547.7 mio. | 111 |
Official annual report
How creditworthy is PHARMACOSMOS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout PHARMACOSMOS A/S
PHARMACOSMOS A/S is a Danish company of the type Aktieselskab based in Holbæk, founded in 1991. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named PHARMACOSMOS PHARMACEUTICALS A/S and SOLOCHEM A/S. The management consists of Tobias Sidelmann Christensen, Claes Christian Strøm and Henrik Parker. The board consists of Jacob Tolstrup (chair), Lars Christensen, Lars Green and Martin Holst Lange. The company is owned by PHARMACOSMOS HOLDING A/S. The company has 327 employees (2026). In 2026, the company reported revenue of DKK 2,176,000,000 and a net result of DKK 714,000,000 compared with DKK 1,622,000,000 the year before. Equity in the 2026 report amounted to DKK 2,775,000,000.